Assignee
ORBUS THERAPEUTICS INC
US·2 granted patents·5 pending applications·3 citations·filing 2016–2024
Top patents by PatentIndex Score
7 records- 0182US10786470B2Formulations for administration of eflornithineORBUS THERAPEUTICS INC·Filed 2017·Granted Sep 29, 2020·2 cites·10 claims
- 0278US11439612B2Formulations for administration of eflornithineORBUS THERAPEUTICS INC·Filed 2020·Granted Sep 13, 2022·1 cites·16 claims
- 0373US2025041256A1Compositions and methods for use of eflornithine and derivatives and analogs thereof to treat cancers, including gliomasORBUS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0472US2023338317A1Formulations for administration of eflornithineORBUS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0556US2019091187A1Compositions and methods for use of eflornithine and derivatives and analogs thereof to treat cancers including gliomasORBUS THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 0654US2017273926A1Compositions and methods for use of eflornithine and derivatives and analogs thereof to treat cancers, including gliomasORBUS THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 0745US2019133985A1Compositions and methods for use of eflornithine and derivatives and analogs thereof to treat cancers, including gliomasORBUS THERAPEUTICS INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ORBUS THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →